Serology Test Market To Reach $10.6 Billion by 2035

Serology test market is projected to grow from $6.5 billion in 2025 to $10.6 billion by 2035, expanding at a CAGR of 5.2% during the forecast period. Growth in the market is primarily driven by the rising global burden of infectious and chronic diseases, increasing demand for diagnostic screening, and expansion of laboratory infrastructure across emerging economies.

Browse the full report description of “Serology Test Market Size, Share & Trends Analysis Report, By Product Type (Instruments, Consumables & Kits, Software & Services), By Technology (ELISA, CLIA, Rapid Tests, Neutralization Assays, Multiplex Immunoassays, RIA), By Application (Infectious Diseases, Autoimmune Diseases, Allergy Testing, Oncology, Others), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/serology-test-market

A key macro driver influencing the serology testing market is the growing prevalence of infectious diseases worldwide. According to the World Health Organization (WHO), infectious diseases remain a leading cause of morbidity globally, with HIV affecting approximately 39 million people worldwide in 2023, while hepatitis B and C infections account for over 350 million chronic cases globally. Additionally, WHO reports that dengue infections have increased significantly, with an estimated 100–400 million infections occurring annually, highlighting the need for rapid and accurate serological diagnostics. These rising disease burdens directly drive the demand for antibody-based testing solutions, particularly in surveillance, diagnosis, and epidemiological monitoring.

Furthermore, the U.S. Food and Drug Administration (FDA) continues to emphasize the importance of serological assays in monitoring immune responses and vaccine efficacy. Increasing vaccination programs and public health screening initiatives are further supporting the adoption of serology testing, especially in developing regions where cost-effective diagnostics are essential.

Among product segments, Bio-fungicides (biological serology reagents analogy for biological testing kits) represent the fastest-growing category, driven by the shift toward biological and sustainable diagnostic solutions. Biological reagents offer advantages such as higher specificity, reduced cross-reactivity, and improved safety profiles, making them increasingly preferred in advanced immunoassay development.

Recent strategic developments by key market players highlight strong innovation and expansion activities:

• In October 2025, Roche Diagnostics expanded access to infectious disease testing through dried blood spots (DBS) and the cobas® Plasma Separation Card (PSC), enabling easier sample collection, eliminating cold-chain requirements, and supporting broader use of serology and molecular diagnostics in remote settings
• In May 2025, Danaher Corporation partnered with AstraZeneca to develop AI-powered precision diagnostics, aiming to accelerate the development and commercialization of advanced diagnostic tests across multiple modalities, including immunoassays.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Technology
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Diasorin S.p.A, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Serology Test Market Report Segment

By Product Type

• Instruments
• Consumables & Kits Software & Services

By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Chemiluminescence Immunoassay (CLIA)
• Lateral Flow Assay (Rapid Tests)
• Neutralization Assays
• Multiplex Immunoassays
• Radioimmunoassay (RIA)

By Application

• Infectious Diseases
• Autoimmune Diseases
• Allergy Testing
• Oncology
• Others

Global Serology Test Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/serology-test-market